3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
138
Neoplasms
5
Neoplasm Metastasis
4
Prostate Adenocarcinoma
3
Recurrence
2
Osteoporosis
2
Advanced Prostate Cancer
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Radiation Injuries
1
Primary Dysautonomias
1
Patients With T1-4 Advanced Prostate Cancer
1
PSA Level Greater Than Two
1
Lymphatic Metastasis
1
Kidney Diseases
1
Hypertension
1
Hot Flashes
1
Hormone Sensitive Prostate Cancer
1
Castration-resistant Prostate Cancer Patients with Oligometastases
1
Castrate Sensitive Prostate Cancer
1
Anemia
1
Interventions
Acupuncture Therapy
4
liposomal amphotericin B
2
Venlafaxine Hydrochloride
2
Isoflavones
2
Gabapentin
2
Caspofungin
2
fezolinetant
1
Vitamin B 6
1
Therapeutics
1
Sugars
1
Soybean Proteins
1
Goserelin
1
Estradiol
1
Estetrol
1
Cyproterone Acetate
1
Caseins
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hot Flashes
×
Goserelin
×
Genitourinary
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled